# Intramuscular Versus Rectal Diclofenac for Pain Relief After Cesarean Section in Women

> **NCT07379762** · PHASE4 · COMPLETED · sponsor: **CMH Multan Institute of Medical Sciences** · enrollment: 60 (actual)

## Conditions studied

- Cesarean Section Pain
- Diclofenac
- Suppository
- Postoperative Pain

## Interventions

- **DRUG:** Diclofenac 75mg
- **DRUG:** Diclofenac 50mg

## Key facts

- **NCT ID:** NCT07379762
- **Lead sponsor:** CMH Multan Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-01
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-07-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07379762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07379762, "Intramuscular Versus Rectal Diclofenac for Pain Relief After Cesarean Section in Women". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07379762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*